Auraptene Mitigates Parkinson's Disease-Like Behavior by Protecting Inhibition of Mitochondrial Respiration and Scavenging Reactive Oxygen Species

Int J Mol Sci. 2019 Jul 11;20(14):3409. doi: 10.3390/ijms20143409.


Current therapeutics for Parkinson's disease (PD) are only effective in providing relief of symptoms such as rigidity, tremors and bradykinesia, and do not exert disease-modifying effects by directly modulating mitochondrial function. Here, we investigated auraptene (AUR) as a potent therapeutic reagent that specifically protects neurotoxin-induced reduction of mitochondrial respiration and inhibits reactive oxygen species (ROS) generation. Further, we explored the mechanism and potency of AUR in protecting dopaminergic neurons. Treatment with AUR significantly increased the viability of substantia nigra (SN)-derived SN4741 embryonic dopaminergic neuronal cells and reduced rotenone-induced mitochondrial ROS production. By inducing antioxidant enzymes AUR treatment also increased oxygen consumption rate. These results indicate that AUR exerts a protective effect against rotenone-induced mitochondrial oxidative damage. We further assessed AUR effects in vivo, investigating tyrosine hydroxylase (TH) expression in the striatum and substantia nigra of MPTP-induced PD model mice and behavioral changes after injection of AUR. AUR treatment improved movement, consistent with the observed increase in the number of dopaminergic neurons in the substantia nigra. These results demonstrate that AUR targets dual pathogenic mechanisms, enhancing mitochondrial respiration and attenuating ROS production, suggesting that the preventative potential of this natural compound could lead to improvement in PD-related neurobiological changes.

Keywords: Parkinson’s disease; antioxidant; auraptene; dopamine neuron; mitochondria; neuroprotection.

MeSH terms

  • Animals
  • Behavior, Animal / drug effects
  • Biomarkers
  • Cell Respiration / drug effects*
  • Coumarins / chemistry
  • Coumarins / pharmacology*
  • Disease Models, Animal
  • Dopaminergic Neurons / drug effects
  • Dopaminergic Neurons / metabolism
  • Free Radical Scavengers / chemistry
  • Free Radical Scavengers / pharmacology*
  • Gene Expression
  • Mice
  • Mitochondria / drug effects*
  • Mitochondria / metabolism*
  • Models, Biological
  • Oxidation-Reduction / drug effects
  • Parkinson Disease / drug therapy
  • Parkinson Disease / metabolism
  • Reactive Oxygen Species / metabolism
  • Tyrosine 3-Monooxygenase / genetics
  • Tyrosine 3-Monooxygenase / metabolism


  • Biomarkers
  • Coumarins
  • Free Radical Scavengers
  • Reactive Oxygen Species
  • Tyrosine 3-Monooxygenase
  • aurapten